financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Takeda Secures European Commission's Approval for Colorectal Cancer Drug Fruzaqla
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Takeda Secures European Commission's Approval for Colorectal Cancer Drug Fruzaqla
Jun 21, 2024 2:06 PM

04:43 PM EDT, 06/21/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Friday it received approval from the European Commission for Fruzaqla for the treatment of previously treated metastatic colorectal cancer.

The company secured the US Food and Drug Administration's approval of Fruzaqla as colorectal cancer treatment in November.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CEO of Brazil oil firm Petrobras to stay in role for now, sources say
CEO of Brazil oil firm Petrobras to stay in role for now, sources say
Apr 10, 2024
BRASILIA, April 10 (Reuters) - Petrobras Chief Executive Jean Paul Prates will remain in his role for now as pressure to remove him from Brazil's state-run oil company has eased, two sources familiar with the situation told Reuters on Wednesday. Word that Prates will stay on for now comes after days of intense speculation that he could be replaced by...
 Ncino Insider Sold Shares Worth $375,928, According to a Recent SEC Filing
Ncino Insider Sold Shares Worth $375,928, According to a Recent SEC Filing
Apr 10, 2024
05:22 PM EDT, 04/10/2024 (MT Newswires) -- Pierre Naude, Director, CEO, on April 08, 2024, sold 10,924 shares in Ncino ( NCNO ) for $375,928. Following the Form 4 filing with the SEC, Naude has control over a total of 1,159,395 shares of the company, with 1,159,395 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1902733/000190273324000089/xslF345X03/wk-form4_1712783765.xml Price: 34.01, Change: +0.65, Percent Change: +1.95...
 Catalyst Pharmaceuticals Insider Sold Shares Worth $392,000, According to a Recent SEC Filing
Catalyst Pharmaceuticals Insider Sold Shares Worth $392,000, According to a Recent SEC Filing
Apr 10, 2024
05:22 PM EDT, 04/10/2024 (MT Newswires) -- David S Tierney, Director, on April 08, 2024, sold 25,000 shares in Catalyst Pharmaceuticals ( CPRX ) for $392,000. Following the Form 4 filing with the SEC, Tierney has control over a total of 348,874 shares of the company, with 348,874 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1369568/000116169724000194/xslF345X03/form4.xml Price: 16, Change: +0.12, Percent Change:...
 Napco Security Technologies Insider Sold Shares Worth $2,037,500, According to a Recent SEC Filing
Napco Security Technologies Insider Sold Shares Worth $2,037,500, According to a Recent SEC Filing
Apr 10, 2024
05:23 PM EDT, 04/10/2024 (MT Newswires) -- Richard Soloway, Director, President, CEO, Chairman, Secretary, on April 08, 2024, sold 50,000 shares in Napco Security Technologies ( NSSC ) for $2,037,500. Following the Form 4 filing with the SEC, Soloway has control over a total of 1,656,010 shares of the company, with 1,656,010 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/69633/000102177124000089/xslF345X03/form4.xml Price: 41,...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved